Mimeographed playbooks gave way to iPads and drones. Athletes are bigger. Roles and recruiting changed. And yet it’s still high school football.

Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...

Official recessions are less frequent, but there is no luck of brutal drawdowns. A negative market narrative, combined with ...

Scientists at the FMI and the University of California-Santa Cruz have found that similar molecular machineries control daily circadian rhythms and ...

Unpacking the beautiful complexity of the female menstrual cycle, and how it might affect our cognitive performance—in ways we wouldn't have imagined.